AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 33687286 — intervention group
Group type: EXPERIMENTAL
Intervention: Nonsurgical treatment
Number of subjects: 119
Study 33687286 — intervention group
Group type: COMPARATOR
Intervention: Surgical treatment
Number of subjects: 119
Study 36355638 — intervention group
Group type: EXPERIMENTAL
Intervention: ACTS2 lay pastoral care facilitator‐led, telephone cognitive‐behavioral intervention
Number of subjects: 9
Study 34126044 — intervention group
Group type: EXPERIMENTAL
Intervention: Stereotactic body radiotherapy at a dose of 24 Gy in two daily fractions
Number of subjects: 229
Study 34126044 — intervention group
Group type: COMPARATOR
Intervention: Conventional external beam radiotherapy at a dose of 20 Gy in five daily fractions
Number of subjects: 229
Study 34126044 — intervention group
Group type: EXPERIMENTAL
Intervention: Stereotactic body radiotherapy
Number of subjects: 229
Study 34126044 — intervention group
Group type: COMPARATOR
Intervention: Conventional external beam radiotherapy
Number of subjects: 229
Study 32717684 — intervention group
Group type: EXPERIMENTAL
Intervention: Fingolimod
Number of subjects: 875
Study 32717684 — intervention group
Group type: COMPARATOR
Intervention: iDMT
Number of subjects: 875
Study 37133765 — intervention group
Group type: EXPERIMENTAL
Intervention: Ileal conduit (IC)
Number of subjects: 100
Study 37133765 — intervention group
Group type: COMPARATOR
Intervention: Single stoma uretero-cutanoustomy (SSUC)
Number of subjects: 100
Study 37133765 — intervention group
Group type: EXPERIMENTAL
Intervention: Functional Assessment of Cancer Therapy‐Bladder Cancer (FACT‐BL)
Number of subjects: 100
Study 33620008 — intervention group
Group type: EXPERIMENTAL
Intervention: LAA-loaded spanlastics
Number of subjects: 0
Study 33620008 — intervention group
Group type: COMPARATOR
Intervention: Topical LAA solution
Number of subjects: 0
Study 33620008 — intervention group
Group type: COMPARATOR
Intervention: UVB treatment
Number of subjects: 0
Study 32377672 — intervention group
Group type: EXPERIMENTAL
Intervention: General Practice Pharmacist (GPP) intervention
Number of subjects: 23
Study 35609943 — intervention group
Group type: EXPERIMENTAL
Intervention: Dapagliflozin
Number of subjects: 102
Study 35609943 — intervention group
Group type: COMPARATOR
Intervention: Control (standard therapy)
Number of subjects: 102
Study 33825213 — intervention group
Group type: EXPERIMENTAL
Intervention: Behavioural Sleep Intervention (BSI)
Number of subjects: 82
Study 32513273 — intervention group
Group type: EXPERIMENTAL
Intervention: TTM-based exercise program (24 weeks)
Number of subjects: 189
Study 32513273 — intervention group
Group type: EXPERIMENTAL
Intervention: TTM-based exercise program
Number of subjects: 189
Study 32513273 — intervention group
Group type: COMPARATOR
Intervention: Control group (same-length exercise program guidance without adherence interventions)
Number of subjects: 189
Study 33710166 — intervention group
Group type: EXPERIMENTAL
Intervention: Light therapy for 12 weeks
Number of subjects: 24
Study 33379181 — intervention group
Group type: EXPERIMENTAL
Intervention: Enriched protein drink (whey protein enriched with leucine and vitamin D)
Number of subjects: 123
Study 33379181 — intervention group
Group type: COMPARATOR
Intervention: Isocaloric control
Number of subjects: 123
Study 34580995 — intervention group
Group type: EXPERIMENTAL
Intervention: Finerenone
Number of subjects: 5674
Study 33719782 — intervention group
Group type: EXPERIMENTAL
Intervention: Brexanolone injection
Number of subjects: 127
Study 33719782 — intervention group
Group type: EXPERIMENTAL
Intervention: Clinical response (≥50% reduction in HAMD-17 total score)
Number of subjects: 127
Study 33719782 — intervention group
Group type: COMPARATOR
Intervention: Baseline HRQoL
Number of subjects: 127
Study 32839221 — intervention group
Group type: COMPARATOR
Intervention: RO7049389 (single dose of 150 to 2,500 mg)
Number of subjects: 83
Study 32839221 — intervention group
Group type: COMPARATOR
Intervention: RO7049389 (multiple doses of 200 to 800 mg)
Number of subjects: 83
Study 32839221 — intervention group
Group type: COMPARATOR
Intervention: RO7049389 (450 mg) under fasted and fed conditions
Number of subjects: 83
Study 32839221 — intervention group
Group type: COMPARATOR
Intervention: RO7049389
Number of subjects: 83
Study 32839221 — intervention group
Group type: COMPARATOR
Intervention: RO7049389 (up to a single dose of 2,500 mg)
Number of subjects: 83
Study 35774427 — intervention group
Group type: EXPERIMENTAL
Intervention: Darbepoetin alfa
Number of subjects: 466
Study 35774427 — intervention group
Group type: COMPARATOR
Intervention: Epoetin alfa
Number of subjects: 466
Study 34284936 — intervention group
Group type: EXPERIMENTAL
Intervention: Mobilization on the day of surgery (day 0 group)
Number of subjects: 167
Study 34284936 — intervention group
Group type: COMPARATOR
Intervention: Mobilization the day after surgery (day 1 group)
Number of subjects: 167
Study 34648192 — intervention group
Group type: EXPERIMENTAL
Intervention: Fluconazole (CYP2C19 inhibitor)
Number of subjects: 12
Study 34648192 — intervention group
Group type: EXPERIMENTAL
Intervention: Ciprofloxacin (CYP1A2 inhibitor)
Number of subjects: 12
Study 34648192 — intervention group
Group type: EXPERIMENTAL
Intervention: Ciprofloxacin/Fluconazole (combination)
Number of subjects: 12
Study 32753063 — intervention group
Group type: EXPERIMENTAL
Intervention: Paracetamol 1g
Number of subjects: 63
Study 32753063 — intervention group
Group type: EXPERIMENTAL
Intervention: Paracetamol-diclofenac (1g + 75mg)
Number of subjects: 63
Study 32753063 — intervention group
Group type: EXPERIMENTAL
Intervention: Paracetamol-tramadol (1g + 100mg)
Number of subjects: 63
Study 35851187 — intervention group
Group type: EXPERIMENTAL
Intervention: Hydrodissection (HD) of the retroprostatic space (RPS) during nsRALP
Number of subjects: 25
Study 35851187 — intervention group
Group type: COMPARATOR
Intervention: Standard nsRALP without HD
Number of subjects: 25
Study 34565001 — intervention group
Group type: EXPERIMENTAL
Intervention: Dexmedetomidine combined with flurbiprofen axetil (D & F Group)
Number of subjects: 60
Study 34565001 — intervention group
Group type: COMPARATOR
Intervention: Flurbiprofen axetil (F Group)
Number of subjects: 60
Study 36858151 — intervention group
Group type: EXPERIMENTAL
Intervention: Apalutamide (240 mg/day) plus ADT
Number of subjects: 1052
Study 36858151 — intervention group
Group type: COMPARATOR
Intervention: Placebo plus ADT
Number of subjects: 1052
Study 34474135 — intervention group
Group type: EXPERIMENTAL
Intervention: Deltopectoral approach (group I)
Number of subjects: 98
Study 34474135 — intervention group
Group type: COMPARATOR
Intervention: Anterosuperior approach (group II)
Number of subjects: 98
Study 32712347 — intervention group
Group type: EXPERIMENTAL
Intervention: Deoxymyoglobin (DeOxy; packaged within 3 min)
Number of subjects: 36
Study 32712347 — intervention group
Group type: EXPERIMENTAL
Intervention: Oxygenation (Oxy; oxygenated in air for 30 min)
Number of subjects: 36
Study 32712347 — intervention group
Group type: EXPERIMENTAL
Intervention: High oxygenation (HiOxy; packaged for 24 h in 80% O2)
Number of subjects: 36
Study 32712347 — intervention group
Group type: EXPERIMENTAL
Intervention: HiOxy steaks frozen for under 6 months
Number of subjects: 36
Study 32712347 — intervention group
Group type: EXPERIMENTAL
Intervention: HiOxy steaks with extended frozen storage and RD
Number of subjects: 36
Study 33400012 — intervention group
Group type: EXPERIMENTAL
Intervention: High-Intensity Laser Therapy (HILT) + exercise
Number of subjects: 63
Study 33400012 — intervention group
Group type: COMPARATOR
Intervention: Sham HILT + exercise
Number of subjects: 63
Study 34968932 — intervention group
Group type: EXPERIMENTAL
Intervention: Online game-based learning with the watch-summarize-question strategy
Number of subjects: 45
Study 34968932 — intervention group
Group type: COMPARATOR
Intervention: Video-based learning (Control)
Number of subjects: 45
Study 34939432 — intervention group
Group type: EXPERIMENTAL
Intervention: Nomogram for predicting cancer-specific survival (CSS)
Number of subjects: 1144
Study 34911731 — intervention group
Group type: EXPERIMENTAL
Intervention: AKI-SCAMP
Number of subjects: 224
Study 33027400 — intervention group
Group type: EXPERIMENTAL
Intervention: Breastfeeding Educational Kit (KEAM)
Number of subjects: 104
Study 33027400 — intervention group
Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 104
Study 35965421 — intervention group
Group type: EXPERIMENTAL
Intervention: Propolis (300 mg)
Number of subjects: 36
Study 35965421 — intervention group
Group type: EXPERIMENTAL
Intervention: Metformin (850 mg)
Number of subjects: 36
Study 35965421 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 36
Study 34706709 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-managed TTNS at home
Number of subjects: 16
Study 34706709 — intervention group
Group type: COMPARATOR
Intervention: HCP-led TTNS in hospital clinic
Number of subjects: 16
Study 35906663 — intervention group
Group type: EXPERIMENTAL
Intervention: Anti-stigma campaign co-created by adolescents and a mobile technology-based electronic decision support system
Number of subjects: 30
Study 35906663 — intervention group
Group type: COMPARATOR
Intervention: Control group (not explicitly defined in the abstract)
Number of subjects: 30
Study 34870118 — intervention group
Group type: EXPERIMENTAL
Intervention: Exercising in shallow water
Number of subjects: 36
Study 34870118 — intervention group
Group type: EXPERIMENTAL
Intervention: Exercising in deep water
Number of subjects: 36
Study 34870118 — intervention group
Group type: COMPARATOR
Intervention: Control group (no exercise)
Number of subjects: 36
Study 35604013 — intervention group
Group type: EXPERIMENTAL
Intervention: Laparoscopic suturing by experts (LSE)
Number of subjects: 16
Study 35604013 — intervention group
Group type: COMPARATOR
Intervention: Laparoscopic suturing by novices (LSN)
Number of subjects: 16
Study 35604013 — intervention group
Group type: EXPERIMENTAL
Intervention: Aggregate performance score for experts (LSE)
Number of subjects: 16
Study 35604013 — intervention group
Group type: COMPARATOR
Intervention: Aggregate performance score for novices (LSN)
Number of subjects: 16
Study 33252432 — intervention group
Group type: EXPERIMENTAL
Intervention: Preconsultation Educational Group Intervention (PEGI)
Number of subjects: 156
Study 33252432 — intervention group
Group type: COMPARATOR
Intervention: Routine education
Number of subjects: 156
Study 33326371 — intervention group
Group type: EXPERIMENTAL
Intervention: Prenatal vitamin D supplementation (2 oral doses of 50,000 IU)
Number of subjects: 283
Study 33326371 — intervention group
Group type: COMPARATOR
Intervention: Control group (routine prenatal care)
Number of subjects: 283
Study 33326371 — intervention group
Group type: EXPERIMENTAL
Intervention: Vitamin D levels (25(OH)D)
Number of subjects: 283
Study 36167565 — intervention group
Group type: EXPERIMENTAL
Intervention: Disease-centred advance directive
Number of subjects: 15
Study 36167565 — intervention group
Group type: COMPARATOR
Intervention: Common advance directive
Number of subjects: 15
Study 33581259 — intervention group
Group type: EXPERIMENTAL
Intervention: Palonosetron 0.25mg
Number of subjects: 18
Study 33581259 — intervention group
Group type: EXPERIMENTAL
Intervention: Palonosetron 0.5mg
Number of subjects: 18
Study 33581259 — intervention group
Group type: EXPERIMENTAL
Intervention: Palonosetron 0.75mg
Number of subjects: 18
Study 33581259 — intervention group
Group type: EXPERIMENTAL
Intervention: Palonosetron (all doses)
Number of subjects: 18
Study 35932359 — intervention group
Group type: EXPERIMENTAL
Intervention: Peer-driven intervention
Number of subjects: 385
Study 35932359 — intervention group
Group type: COMPARATOR
Intervention: Control networks (HIV testing and counseling)
Number of subjects: 385
Study 32539224 — intervention group
Group type: EXPERIMENTAL
Intervention: Dapagliflozin 10 mg
Number of subjects: 4744
Study 32539224 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 4744
Study 32265083 — intervention group
Group type: EXPERIMENTAL
Intervention: Dexmedetomidine infusion (0.7 μg/kg/h in the operating room and 0.4 μg/kg/h in the ICU)
Number of subjects: 169
Study 32265083 — intervention group
Group type: EXPERIMENTAL
Intervention: Dexmedetomidine infusion
Number of subjects: 169
Study 32265083 — intervention group
Group type: EXPERIMENTAL
Intervention: Dexmedetomidine administration
Number of subjects: 169
Study 32974838 — intervention group
Group type: EXPERIMENTAL
Intervention: damoctocog alfa pegol
Number of subjects: 18
Study 32974838 — intervention group
Group type: COMPARATOR
Intervention: rurioctocog alfa pegol
Number of subjects: 18
Study 35994795 — intervention group
Group type: EXPERIMENTAL
Intervention: Aromatherapy through the skin and by inhalation
Number of subjects: 70
Study 35994795 — intervention group
Group type: COMPARATOR
Intervention: Routine nursing care (Control)
Number of subjects: 70
Study 34516363 — intervention group
Group type: EXPERIMENTAL
Intervention: Brazil nut supplementation (1 Brazil nut/day for 3 months)
Number of subjects: 36
Study 34516363 — intervention group
Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 36
Study 35805060 — intervention group
Group type: EXPERIMENTAL
Intervention: Geriatric Assessment (GA)‐driven interventions and follow‐up for 24 months
Number of subjects: 499
Study 35805060 — intervention group
Group type: COMPARATOR
Intervention: Standard of care
Number of subjects: 499
Study 35022796 — intervention group
Group type: EXPERIMENTAL
Intervention: JUUL e‐cigarettes for 6 weeks
Number of subjects: 114
Study 32516811 — intervention group
Group type: EXPERIMENTAL
Intervention: Closed wound drain (Redon)
Number of subjects: 800
Study 32516811 — intervention group
Group type: COMPARATOR
Intervention: No drain (Control)
Number of subjects: 800
Study 34304467 — intervention group
Group type: EXPERIMENTAL
Intervention: Tympanic tympanoplasty under otoendoscope (study group)
Number of subjects: 176
Study 34304467 — intervention group
Group type: COMPARATOR
Intervention: Intratympanic injection of methylprednisolone (control group)
Number of subjects: 176
Study 34304467 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 176
Study 32629078 — intervention group
Group type: EXPERIMENTAL
Intervention: Dose-escalated arm (up to 95 Gy prescribed to the tumor)
Number of subjects: 539
Study 32629078 — intervention group
Group type: EXPERIMENTAL
Intervention: Replanning of 21 plans
Number of subjects: 539
Study 32629078 — intervention group
Group type: EXPERIMENTAL
Intervention: Prediction model for tumor D98%
Number of subjects: 539
Study 32629078 — intervention group
Group type: COMPARATOR
Intervention: Both arms (dose constraints to organs at risk)
Number of subjects: 539
Study 36435230 — intervention group
Group type: EXPERIMENTAL
Intervention: Teacher-designed games (TDG)
Number of subjects: 30
Study 36435230 — intervention group
Group type: EXPERIMENTAL
Intervention: Child-designed games (CDG)
Number of subjects: 30
Study 36435230 — intervention group
Group type: COMPARATOR
Intervention: Both groups (TDG and CDG)
Number of subjects: 30
Study 32935315 — intervention group
Group type: EXPERIMENTAL
Intervention: Higher-knowledge physicians
Number of subjects: 62
Study 32935315 — intervention group
Group type: COMPARATOR
Intervention: Lower-knowledge physicians
Number of subjects: 62
Study 32935315 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 62
Study 32911776 — intervention group
Group type: EXPERIMENTAL
Intervention: Messages about the environment’s influence on obesity (Study 1 & 2)
Number of subjects: 4391
Study 32911776 — intervention group
Group type: EXPERIMENTAL
Intervention: Messages about the environment’s influence on human behaviour (Study 1)
Number of subjects: 4391
Study 32911776 — intervention group
Group type: COMPARATOR
Intervention: No message (Control group)
Number of subjects: 4391
Study 36125170 — intervention group
Group type: EXPERIMENTAL
Intervention: Advertisement for a hypothetical cold sore medicine
Number of subjects: 1295
Study 36125170 — intervention group
Group type: COMPARATOR
Intervention: Control group (no advertisement)
Number of subjects: 1295
Study 33811685 — intervention group
Group type: EXPERIMENTAL
Intervention: Pentraxin-3 (PTX3) detected in saliva
Number of subjects: 106
Study 33811685 — intervention group
Group type: EXPERIMENTAL
Intervention: Pentraxin-3 (PTX3)
Number of subjects: 106
Study 32929897 — intervention group
Group type: EXPERIMENTAL
Intervention: AIHIP system (trial group)
Number of subjects: 60
Study 32929897 — intervention group
Group type: COMPARATOR
Intervention: Acetate templating (control group)
Number of subjects: 60
Study 32929897 — intervention group
Group type: EXPERIMENTAL
Intervention: Trial group
Number of subjects: 60
Study 32929897 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 60
Study 35840918 — intervention group
Group type: EXPERIMENTAL
Intervention: Orem-based self-care education (five 60-minute sessions, one session per week)
Number of subjects: 100
Study 35840918 — intervention group
Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 100
Study 34240443 — intervention group
Group type: EXPERIMENTAL
Intervention: Constrained Lasso approach with hierarchical interaction restriction
Number of subjects: 2569
Study 34240443 — intervention group
Group type: COMPARATOR
Intervention: Unstructured Lasso
Number of subjects: 2569
Study 32748303 — intervention group
Group type: EXPERIMENTAL
Intervention: Multi-component upper-extremity intervention
Number of subjects: 73
Study 34674922 — intervention group
Group type: EXPERIMENTAL
Intervention: Mobile app for teaching communication skills about diagnostic uncertainty
Number of subjects: 109
Study 34674922 — intervention group
Group type: EXPERIMENTAL
Intervention: Mobile app use
Number of subjects: 109
Study 34674922 — intervention group
Group type: EXPERIMENTAL
Intervention: Senior residents
Number of subjects: 109
Study 34537448 — intervention group
Group type: EXPERIMENTAL
Intervention: Bronchoscopic airway clearance therapy (B-ACT)
Number of subjects: 189
Study 34537448 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 189
Study 35066509 — intervention group
Group type: EXPERIMENTAL
Intervention: Esmolol
Number of subjects: 40
Study 35066509 — intervention group
Group type: COMPARATOR
Intervention: Usual care (Control)
Number of subjects: 40
Study 33228480 — intervention group
Group type: EXPERIMENTAL
Intervention: max t‐test‐type statistics (multiple contrast tests)
Number of subjects: 0
Study 33228480 — intervention group
Group type: EXPERIMENTAL
Intervention: randomization‐based approach
Number of subjects: 0
Study 33228480 — intervention group
Group type: EXPERIMENTAL
Intervention: simulation studies
Number of subjects: 0
Study 33228480 — intervention group
Group type: EXPERIMENTAL
Intervention: real data set
Number of subjects: 0
Study 35811511 — intervention group
Group type: EXPERIMENTAL
Intervention: Compression stocking A (interface pressure 18-20 mmHg)
Number of subjects: 0
Study 35811511 — intervention group
Group type: EXPERIMENTAL
Intervention: Compression stocking B (interface pressure 18-20 mmHg)
Number of subjects: 0
Study 35811511 — intervention group
Group type: COMPARATOR
Intervention: Below-knee low-pressure support stocking (LPSS) (interface pressure 8-10 mmHg)
Number of subjects: 0
Study 35811511 — intervention group
Group type: COMPARATOR
Intervention: Compression stockings A and B compared to LPSS
Number of subjects: 0
Study 35811511 — intervention group
Group type: EXPERIMENTAL
Intervention: All three types of stockings
Number of subjects: 0
Study 36138504 — intervention group
Group type: EXPERIMENTAL
Intervention: Guided Pelvic Floor Exercises
Number of subjects: 62
Study 36138504 — intervention group
Group type: COMPARATOR
Intervention: Written information (control group)
Number of subjects: 62
Study 34521593 — intervention group
Group type: EXPERIMENTAL
Intervention: 1,25-hydroxyvitamin D3 plus amoxicillin, clarithromycin, and esomeprazole for 2 weeks
Number of subjects: 150
Study 34521593 — intervention group
Group type: COMPARATOR
Intervention: Standard clarithromycin-based triple therapy (amoxicillin, clarithromycin, and esomeprazole for 2 weeks)
Number of subjects: 150
Study 35737833 — intervention group
Group type: EXPERIMENTAL
Intervention: Transfluthrin-based spatial repellent
Number of subjects: 16783
Study 32200819 — intervention group
Group type: EXPERIMENTAL
Intervention: Treatment group 1
Number of subjects: 438
Study 32200819 — intervention group
Group type: EXPERIMENTAL
Intervention: Treatment group 2
Number of subjects: 438
Study 32200819 — intervention group
Group type: EXPERIMENTAL
Intervention: Treatment group 3
Number of subjects: 438
Study 32200819 — intervention group
Group type: EXPERIMENTAL
Intervention: Baseline visual acuity
Number of subjects: 438
Study 32200819 — intervention group
Group type: EXPERIMENTAL
Intervention: Older age
Number of subjects: 438
Study 36178909 — intervention group
Group type: EXPERIMENTAL
Intervention: Remimazolam
Number of subjects: 90
Study 36178909 — intervention group
Group type: COMPARATOR
Intervention: Propofol
Number of subjects: 90
Study 35129534 — intervention group
Group type: EXPERIMENTAL
Intervention: 4-day antibiotic duration (experimental arm of STOP-IT RCT)
Number of subjects: 4384
Study 35129534 — intervention group
Group type: COMPARATOR
Intervention: Standard antibiotic duration (control group)
Number of subjects: 4384
Study 32366554 — intervention group
Group type: EXPERIMENTAL
Intervention: Local network feature model
Number of subjects: 40
Study 32366554 — intervention group
Group type: EXPERIMENTAL
Intervention: Global network feature model
Number of subjects: 40
Study 32366554 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined model of local and global features
Number of subjects: 40
Study 33369038 — intervention group
Group type: EXPERIMENTAL
Intervention: FAMily‐Oriented Support (FAMOS) intervention, cognitive-behavioural manualised home intervention for 6 months
Number of subjects: 109
Study 33369038 — intervention group
Group type: EXPERIMENTAL
Intervention: FAMily‐Oriented Support (FAMOS) intervention
Number of subjects: 109
Study 33369038 — intervention group
Group type: COMPARATOR
Intervention: Usual psychosocial care (Control)
Number of subjects: 109
Study 33225918 — intervention group
Group type: EXPERIMENTAL
Intervention: Praziquantel (PZQ) treatment
Number of subjects: 5679
Study 36163806 — intervention group
Group type: EXPERIMENTAL
Intervention: Ivosidenib (IVO) 500 mg once daily plus Azacitidine (AZA) 75 mg/m2 for 7 days in 28-day cycles
Number of subjects: 146
Study 36163806 — intervention group
Group type: COMPARATOR
Intervention: Placebo (PBO) plus Azacitidine (AZA) 75 mg/m2 for 7 days in 28-day cycles
Number of subjects: 146
Study 34628889 — intervention group
Group type: EXPERIMENTAL
Intervention: Vitamin D3 (800-1,200 IU/day)
Number of subjects: 184
Study 34628889 — intervention group
Group type: COMPARATOR
Intervention: ATD (methimazole, 15-30 mg/day)
Number of subjects: 184
Study 36055467 — intervention group
Group type: EXPERIMENTAL
Intervention: H‐1337 Ophthalmic Solution 0.06%
Number of subjects: 87
Study 36055467 — intervention group
Group type: EXPERIMENTAL
Intervention: H‐1337 Ophthalmic Solution 0.20%
Number of subjects: 87
Study 36055467 — intervention group
Group type: EXPERIMENTAL
Intervention: H‐1337 Ophthalmic Solution 0.60%
Number of subjects: 87